In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Host:
Anita L. Nelson, MD
Professor and Chair of Obstetrics & Gynecology
Western University of Health Sciences, Pomona, CA
Professor Emeritus, Obstetrics & Gynecology,
David Geffen School of Medicine at UCLA
Clinical Professor Obstetrics & Gynecology,
University Southern California, Los Angeles, CA
Consulting Fees: Agile Therapeutics, Bayer HealthCare, Mayne Pharma, Pfizer, TherapeuticsMD
Commercial Interest Speakers Bureau: Agile Therapeutics, Bayer HealthCare, Mayne Pharma, Myovant Sciences, Organon/Merck & Co., TherapeuticsMD
Contracted Research: Mylan Pharmaceuticals, Myovant Sciences, Organon/Merck & Co., Sagami Rubber Industries, Sebela Pharmaceuticals
Faculty:
Linda D. Bradley, MD
Professor, Obstetrics and Gynecology and Reproductive Biology
Cleveland Clinic
Cleveland, OH
No relevant relationship reported
Eliot A. Brinton, MD, FAHA, FNLA, FACE
President
Utah Lipid Center
Salt Lake City, UT
Consulting Fees:Amarin, Esperion, Kowa
Commercial Interest Speakers Bureau:Amarin, Amgen, Boehringer, Kowa, Merck, Nova, Regeneron, Sanofi
Cassandra B. Donnelly, DO
Regional Medical Director
Piedmont Urgent Care
Atlanta, GA
No relevant relationship reported
David L. Eisenberg, MD, MPH, FACOG
Associate Professor
Department of Obstetrics & Gynecology
Washington University School of Medicine in St. Louis
St. Louis, MO
Consulting Fees: Evofem, Femosys, Medicines360, Sebela Pharmaceuticals Inc./ACI Clinical
Commercial Interest Speakers Bureau: Evofem, Merck
Contracted Research: Medinines360, Merck
Ownership Interest: Femosys
Brooke M. Faught, DNP, WHNP, NCMP, FAANP, IF
Director of the Women’s Institute for Sexual Health (WISH)
Nashville, TN
Consulting Fees: Mayne Pharm, SCYNEXIS, Trophikos
Speakers Bureau: Agile Therapeutics, JDS Therapeutics, Palatin, TherapeuticsMD
Contracted Research: Dare Bioscience, IPSEN Innovation
Peter Goadsby, MD, PhD, DSc
Professor of Neurology
David Geffen School of Medicine at UCLA
Los Angeles, CA
Consulting Fees: Aeon Biopharma, Amgen, Allergan, Biohaven Pharmaceuticals Inc., Eli Lilly and Company, Epalex, GlaxoSmithKline, Impel Neuropharma, Lundbeck, Novartis, Pfizer
Research Grants: Amgen, Celgene, Eli Lilly and Company
Kathleen Mullin, MD
Medical Director, Clinical Research
New England Institute for Neurology and Headache
Stamford, CT
Consulting Fees: Biohaven Pharmaceuticals, Lilly
Speaker Bureau: Biohaven Pharmaceuticals, Lilly, Teva
Paul Nyirjesy, MD
Professor of Obstetrics & Gynecology
Co-director, Jefferson Vulvovaginal Health Center
Sidney Kimmel Medical College at Thomas Jefferson University
Philadelphia, PA
Consulting Fees: Hologic, Inc., Mycovia Pharmaceuticals, SCYNEXIS, Inc.
Gregory S. Pokrywka MD, FACP, FNLA, FASPC, NCMP
Director: Baltimore Lipid Center
Assistant Professor
Johns Hopkins University School of Medicine
Baltimore, MD
Commercial Interest Speakers Bureau: Amarin, Amgen, Esperion
Sukhbir Sony Singh, MD
Professor, Department of Obstetrics & Gynecology
The Ottawa Hospital/University of Ottawa
Associate Scientist and the Dr. E. Jolly Research Chair in Gynecologic Surgery
The Ottawa Hospital Research Institute
Ottawa, ON Canada
Consulting Fees & Speaker Bureau: AbbVie
Charles P. Vega, MD
Clinical Professor, Family Medicine
School of Medicine
University of California, Irvine
Orange, CA
No relevant relationship reported
Sateria Venable
Founder & CEO of The Fibroid Foundation
Bethesda, MD
Consulting Fees: AbbVie
Karol Watson, MD, PhD
Professor of Medicine/Cardiology
Co-director, UCLA Program in Preventive Cardiology
Director, UCLA Barbra Streisand Women's Heart Health Program
David Geffen School of Medicine at UCLA
Los Angeles, CA
Consulting Fees: Amarin, Amgen, Boehringer-Ingelheim, Lilly, Esperion, Novo Nordisk
Reviewers/Content Planners/Authors:
- Sean T. Barrett has nothing to disclose.
- Ben Caref, PhD, has nothing to disclose.
- Barry A. Fiedel, PhD, has nothing to disclose.
- Sue Grossman has nothing to disclose.
- Amanda Hilferty has nothing to disclose.
- Nick Lomardi has no relevant relationship to report.
- Libby Lurwick has nothing to disclose.
- Brian P. McDonough, MD, FAAFP, has nothing to disclose.
- Estelle Perera has nothing to disclose.
- Colleen Resnick has nothing to disclose.
- Robert Schneider, MSW has nothing to disclose.
Facebook Comments